India's First Integrated Digital Accelerator

Syntimmune Sectors, Funding and Contact Details

Boston, Massachusetts, United States

Syntimmune

Syntimmune develops differentiated drug candidates in a wide range of autoimmune diseases.

Status

Acquired

Sectors

• Biotechnology • Emergency Medicine • Health Care • Medical • Pharmaceutical

Employees

Founders

Laurence Blumberg, Richard Blumberg

Last Funding

6/21/2017

Listed/Private

Private

Funding Stage

Size

Founded

January 1, 2013

Investors

Apple Tree Partners, Partners Innovation Fund, Baxalta Ventures

Acquisitions

Ticker

NA

Study your competition to stay ahead